Weekend news – Peru suspends Sinopharm COVID-19 vaccine trial after ‘adverse event’

This is from the weekend, posting as an ICYMI on China vaccine developer Sinopharm Group.

  • is conducting trials in Peru
  • with around 12,000 volunteers
But trials have been suspended due to a “serious adverse event” that occurred with one of the volunteers. The event is “under investigation to determine if it is related to the vaccine or if there is another explanation”.